Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "Microbial & Host Biomolecules" refers to the diverse and complex set of molecules produced by both microorganisms (such as bacteria, archaea, fungi, and viruses) and their multicellular hosts (such as humans or animals), particularly within the context of their mutual interactions. These include microbial metabolites (e.g., short-chain fatty acids, tryptophan catabolites, indole derivatives), microbial surface components, and virulence factors, as well as host-derived proteins, peptides, nucleic acids, and signaling molecules involved in immune recognition, defense, or tolerance[2][6][7]. Rather than representing a single molecular entity, this designation covers a multitude of molecules and pathways mediating metabolic exchange, immune modulation, colonization, commensalism, and pathogenesis at the host-microbe interface. It is therefore not a precise pharmaceutical or biological target but a descriptor for an entire functional and mechanistic landscape. Any research, drug discovery, or therapeutic targeting efforts must be directed at specific molecules within this broad space.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial & Host Biomolecules.